Summary

In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation

Published: May 06, 2020
doi:

Summary

Presented here is a protocol to perform genetic manipulation in the embryonic ferret brain using in utero electroporation. This method allows for targeting of neural progenitor cells in the neocortex in vivo.

Abstract

Manipulation of gene expression in vivo during embryonic development is the method of choice when analyzing the role of individual genes during mammalian development. In utero electroporation is a key technique for the manipulation of gene expression in the embryonic mammalian brain in vivo. A protocol for in utero electroporation of the embryonic neocortex of ferrets, a small carnivore, is presented here. The ferret is increasingly being used as a model for neocortex development, because its neocortex exhibits a series of anatomical, histological, cellular, and molecular features that are also present in human and nonhuman primates, but absent in rodent models, such as mouse or rat. In utero electroporation was performed at embryonic day (E) 33, a midneurogenesis stage in ferret. In utero electroporation targets neural progenitor cells lining the lateral ventricles of the brain. During neurogenesis, these progenitor cells give rise to all other neural cell types. This work shows representative results and analyses at E37, postnatal day (P) 1, and P16, corresponding to 4, 9, and 24 days after in utero electroporation, respectively. At earlier stages, the progeny of targeted cells consists mainly of various neural progenitor subtypes, whereas at later stages most labeled cells are postmitotic neurons. Thus, in utero electroporation enables the study of the effect of genetic manipulation on the cellular and molecular features of various types of neural cells. Through its effect on various cell populations, in utero electroporation can also be used for the manipulation of histological and anatomical features of the ferret neocortex. Importantly, all these effects are acute and are performed with a spatiotemporal specificity determined by the user.

Introduction

The neocortex is the outer sheet of the mammalian cerebrum and the seat of higher cognitive functions1,2,3,4,5. In order to achieve an acute genetic manipulation in the mammalian neocortex in vivo during the embryonic development, two different methods have been explored: viral infection6 and in utero electroporation7. Both methods allow efficient targeting of neocortical cells but suffer from some limitations. The major advantage of in utero electroporation compared to viral infection is the ability to achieve spatial specificity within the neocortex, which is achieved by regulating the direction of the electric field.

Since electroporation was first shown to facilitate the entry of DNA into the cells in vitro8, it has been applied to deliver DNA into various vertebrates in vivo. In developmental neuroscience, in utero electroporation of the mouse neocortex was first reported in 20019,10. This method consists of an injection of the DNA mixture in the lateral ventricle of the embryonic brain and subsequent application of the electric field using tweezer electrodes, which allows spatial precision7,11. In utero electroporation has since been applied to deliver nucleic acids in order to manipulate the expression of endogenous or ectopically added genes in the mouse neocortex. Important progress has been made recently by applying the methodology of CRISPR/Cas9-mediated genome editing via in utero electroporation in the mouse neocortex to perform (1) gene disruption in postmitotic neurons12,13 and neural progenitor cells14, and (2) genome15 and epigenome16 editing.

Very soon after the first report in mouse, in utero electroporation was applied to the embryonic rat neocortex17,18. Non-rodents remained a challenge until the first in utero electroporation of ferrets, a small carnivore, was reported in 201219,20. Since then, in utero electroporation of ferrets has been applied to study the mechanisms of neocortex development by labeling neural progenitors and neurons20,21,22,23, manipulating the expression of endogenous genes, including the use of CRISPR/Cas9 technology24, and by delivering ectopic genes21,22,25, including human-specific genes26. Furthermore, in utero electroporation of ferrets has been used to address features of human neocortex development in pathological conditions27,28.

In the context of neocortex development, the advantages of using ferrets as a model organism compared to mice are due to the fact that ferrets better recapitulate a series of human-like features. At the anatomical level, ferrets exhibit a characteristic pattern of cortical folding, which is also present in human and most other primates, but is completely absent in mice or rats4,29,30,31. At the histological level ferrets have two distinct subventricular germinal zones, referred to as the inner and outer subventricular zones (ISVZ and OSVZ, respectively)32,33, separated by the inner fiber layer23. These features are also shared with primates, including humans, but not with mice34. The ISVZ and OSVZ in ferrets and humans are populated with abundant neural progenitor cells, whereas the subventricular zone (SVZ) of mice contains only sparse neural progenitors21,32,35,36. At a cellular level, ferrets exhibit a high proportion of a subtype of neural progenitors referred to as basal or outer radial glia (bRG or oRG, respectively), which are deemed instrumental for the evolutionary expansion of the mammalian neocortex34,37,38. bRG are hence highly abundant in the fetal human and embryonic ferret neocortex, but they are very rare in the embryonic mouse neocortex35,36. Furthermore, ferret bRG shows morphological heterogeneity similar to that of human bRG, far superior to mouse bRG21. Finally, at a molecular level, developing ferret neocortex shows gene expression patterns highly similar to those of fetal human neocortex, which are presumed to control the development of cortical folding, among other things39.

The cell biological and molecular characteristics of ferret bRG render them highly proliferative, similar to human bRG. This results in an increased production of neurons and development of an expanded and highly complex neocortex34. These characteristics make ferrets excellent model organisms for studying human-like features of neocortex development that cannot be modelled in mice26,40. To take full advantage of the ferret as a model organism the presented method was developed. It consists of in utero electroporation of E33 ferret embryos with a plasmid expressing GFP (pGFP) under the control of a ubiquitous promoter, CAG. The electroporated embryos can then be analyzed embryonically or postnatally. In order to reduce the number of sacrificed animals, female ferrets (jills) are sterilized by hysterectomy and donated for adoption as pets. If the targeted embryos are harvested at embryonic stages, a second surgery is performed and the embryos are removed by a caesarian section, whereas the jills are hysterectomized. If the targeted embryos are analyzed at postnatal stages, the jills are hysterectomized after the pups have been weaned or sacrificed. Hence, a protocol for the hysterectomy of jills is also presented.

Protocol

All experimental procedures were conducted in agreement with the German Animal Welfare Legislation after approval by the Landesdirektion Sachsen (licenses TVV 2/2015 and TVV 21/2017).

1. Preparation for in utero electroporation

  1. Prepare the DNA mixture. In this protocol a final concentration of 1 µg/µL of pGFP is used. Dissolve DNA in PBS and supplement with 0.1% Fast Green to facilitate visualization. Once prepared, mix the DNA mixture by pipetting up and down several times or by finger tapping. Store at room temperature until use.
    NOTE: For coelectroporations, the DNA mixture is prepared to contain a final concentration of 1 µg/µL of plasmid encoding a gene of interest along with 0.5 µg/µL of pGFP diluted in PBS.
  2. Prepare the surgery table with all the required tools and instruments.
  3. Pull glass capillaries using the micropipette puller. Adjust the diameter of the capillary tip by cutting off the distal part of the capillary using forceps as previously described41.

2. Preparation of ferrets for surgery

  1. Keep the pregnant jills with embryos at E33 fasting for at least 3 h before the surgery to reduce the risk of vomiting.
  2. Prior to the surgery sterilize all the tools by autoclaving. Perform the surgery in a specially assigned room in aseptic conditions to eliminate potential sources of contamination.
  3. Place the pregnant jill in the narcosis box with 4% isoflurane.
  4. When anesthetized, place the ferret on the operation table with a heat pad and attach the narcosis mask with a constant 2–3% isoflurane flow to the nose. To ensure the appropriate level of anesthesia, check for the lack of the following reflexes:
    1. The palpebral reflex by touching the periocular skin
    2. The flexor reflex by pinching the skin between the 2nd and 3rd, or 3rd and 4th toe of both hind limbs
    3. If the palpebral reflex is absent and flexor reflex is clearly reduced, check for the pain reflex by pinching one toe of each hind limb.
      NOTE: Ensure to have a stethoscope at hand to monitor heart rate and rhythm if required.
  5. Inject the ferret subcutaneously with analgesic (0.1 mL of metamizol, 50 mg/kg of body weight), antibiotic (0.1 mL/kg of body weight of 20 mg/kg of amoxicillin + clavulanic acid), and glucose (10 mL of 5% glucose solution).
  6. Place a drop of eye ointment solution on the eyes to prevent eye dehydration during the surgical procedure.
  7. Shave the ferret belly using a shaver.
  8. Clean the skin with water and soap, disinfect the belly with 70% ethanol scrub, disinfect 2x with iodine, and let it dry.

3. In utero electroporation of ferrets

  1. Ensure that the surgical area is sterile: place sterile surgical tools on sterile tissues, and change coat and gloves.
  2. Place a sterile surgical drape on the animal.
  3. Using a scalpel, surgically open the belly at the linea alba with a ~5 cm long cut.
  4. Cut the muscle layer using scissors.
  5. Place gauze swabs around the incision site and wet them with PBS. The gauze swabs will absorb the additional PBS that will be added during the surgery.
    NOTE: Maintain heat and PBS support throughout the surgery.
  6. Expose the ferret uterus and place it on the gauze swabs.
  7. Load a glass capillary with the injection solution using a pipette with a long loading tip. Ensure that the loading volume is approximately between 5–20 µL depending on the number of embryos and number of different experimental conditions. The average injected volume per embryo is 3–5 µL. Attach the loaded glass capillary to a holder and connect the other side of the holder to a tube and a mouthpiece.
  8. Inspect the first embryo and find the head.
  9. Place the fiber optic light source next to the embryo's head to facilitate visualization.
    NOTE: Ferret uterine walls are very dark, and it is difficult to see through them unless light is shined directly on them.
  10. Perform a single intraventricular injection into the ventricle of one of the cerebral hemispheres and keep the other hemisphere intact to serve as an internal control. The ventricle itself is not easily distinct by eye, so its location is estimated based on the location of the pigmented iris, which is visible. The intraventricular injection is done by taking the holder attached to the glass capillary and penetrating the skin, skull, and cerebral tissue with the tip of the glass capillary.
    NOTE: Make sure to not damage the placenta, which is darker than murine placentas.
    1. When the tip of the glass capillary is in the ventricle, inject approximately 3–5 µL of the injection solution by mouth-pipetting using the mouthpiece connected to the glass capillary holder. Because the injected solution contains 0.1% Fast Green, the injected ventricle will now turn dark green, and will be visible as a kidney-shaped structure.
  11. Place the tweezer electrodes on the uterus above the embryo's head so that the positive pole is placed above the area that will be targeted and the negative pole below the injected area.
  12. Set the following electroporation conditions on the electroporator: Pulse length = 50 ms; Pulse voltage = 100 V; Pulse interval = 1 s; Number of pulses = 5. Then, press the "Pulse" button on the electroporator.
  13. Quickly drop several drops of warm 1x PBS on the electroporated embryo.
  14. Repeat the procedure for all the embryos. Keep the uterus constantly wet with warm PBS.
    NOTE: If the first embryos facing the vagina are not easily accessible, it is best to not electroporate them.
  15. When all the embryos are electroporated, place the uterus back into the peritoneal cavity.
  16. Suture the muscle layer with the peritoneum using a 4-0 suture.
  17. Suture the skin using the same thickness and spray the wound with aluminum spray.
  18. Place the animal in a cage and keep it warm with a heat source. Carefully monitor the animal until it wakes up.

4. Postoperative care and housing of targeted animals

  1. For 3 days after the surgery ensure that the animals are undergoing the following postoperative care: 20 mg/kg amoxicillin (antibiotic) 1x daily; 25 mg/kg metamizol (analgesic) 3x daily.
  2. Ensure that the ferrets are housed individually.
  3. Ensure that the ferrets are examined by a veterinary at least 1x per day.
  4. Ensure that the ferrets are disturbed as little as possible during delivery.
  5. After the pups are weaned or sacrificed, prepare the jills for hysterectomy.

5. Hysterectomy of ferrets

NOTE: A hysterectomy is performed to reduce the number of sacrificed animals so that the sterilized animals can be donated for adoption as pets. The presurgical procedure for hysterectomy is the same as in step 2.

  1. Shave and sterilize the ferret belly as described in steps 3.1 and 3.2.
  2. Surgically open the belly at the linea alba. Cut the muscle layer. Lift the muscle layer and shelter the gut with a finger while fully opening the muscle layer.
  3. Place gauze swabs around the incision site and wet them with sterile PBS. Expose the ferret uterus and the ovaries and place them on the gauze swabs.
  4. Start the hysterectomy on one side by ligating the arteria ovarica and vena ovarica cranial to the mesovar. Put a clamp on each side of the ligation and perform another ligation cranial to the clamps. Attach the third clamp at the ends of the ligation to save them. Repeat on the other side.
  5. Cut between the clamps and detach the cornua uteri from the mesentery on both sides.
  6. Ligate the arteria uterina on both uterine sides caudal to the ostium uteri. Then ligate the vagina and fix the ligature. Attach the clamp at the ends of the ligations to save them. Put two clamps cranial to the ligature. Cut between the clamps and detach the uterus from vagina. Remove the uterus and ovaries and dispose of them. Scrape the residual mucous membrane from the uterus butt.
  7. Detach all the remaining clamps and shorten the ligature ends. Make sure to control for bleeding after the clamps have been removed.
  8. Suture the muscle layer and the skin as described in steps 3.16 and 3.17. Follow the postoperative protocol as in steps 3.18 and 4.1–4.3. Keep the animals in the animal facility for at least 2 weeks with regular veterinary visits. After the animals are fully recovered, they can be donated for adoption.

Representative Results

In utero electroporation of ferrets at E33 resulted in targeting of the neural progenitor cells lining the ventricular surface of the embryonic neocortex (Figure 1). These cells are called apical progenitors and are highly proliferative, giving rise to all other cell types during development. Upon asymmetric division, apical progenitors generated another apical progenitor and a more differentiated cell, typically a basal progenitor (BP), which delaminated from the ventricular surface. BPs migrated into the secondary germinal zone, the SVZ. When the electroporation was performed at E33, many newborn BPs migrated to the basal-most part of the SVZ, where they formed the OSVZ22.

When the effects of electroporation were examined 4 days later at E37, most of the targeted cells and their progeny were still in the germinal zones (VZ, ISVZ, and OSVZ, see Figure 2A) and cells were seldom present further basally in the cortical plate (CP). The progeny of targeted cells mainly consisted of neural progenitor types and newborn neurons. The progenitor identity could be examined by immunofluorescence for markers of cycling cells, such as PCNA26 (Figure 2B, C), whereas a subset of progenitors undergoing mitosis could be shown by markers such as phosphohistone 3 (PH3)21 (Figure 2D).

At P0, 8 days after electroporation, the progeny of targeted cells spread in all histological layers (Figure 3A, B). At this stage, BPs were particularly abundant and bRG were readily identifiable. Using a combination of transcription factor markers, different BP populations could be revealed. Sox2 is a marker of proliferative progenitor cells, including bRG26. Tbr2 is a marker of neurogenic BPs, which are mainly intermediate progenitors26 (Figure 3B). Because the embryos were co-electroporated with a plasmid encoding GFP, the morphology of neural progenitors could be examined by tracking the GFP signal. This is particularly important in the context of BPs, which come in two major morphotypes: multipolar cells, which are largely intermediate progenitors, and radial cells, which are bRG21. Hence, Sox2+ Tbr2– radial cells in the OSVZ are the key cell population of interest for studying bRG26.

By P16, a majority of targeted cells stopped dividing and differentiated into neurons and glia. Therefore, these cell types are best examined at this stage. In addition to various neuronal and glial subtypes, ferret P16 neocortex exhibited the characteristics pattern of folding (Figure 3C). At this stage most major gyri and sulci were already present and prospective brain areas could be identified31. Ferret brain continued maturing after P16, when processes such as myelination and synaptogenesis take place.

Figure 1
Figure 1: Targeting neural cells by in utero electroporation of the ferret neocortex. In utero electroporation of the ferret neocortex at E33 resulted in targeting of apical progenitors. During development these cells give rise to all other cell types. Basal progenitors were best studied at later embryonic (E37) and perinatal (P0) stages. Neurons were best studied at postnatal stages, such as P16. Cortical layers: VZ = ventricular zone; ISVZ = inner subventricular zone; OSVZ = outer subventricular zone; IZ = intermediate zone; CP = cortical plate; GZ = germinal zones (VZ+SVZ); WM = white matter. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Example of E37 ferret neocortex after in utero electroporation at E33. (A and B) Section of the E37 ferret neocortex; green, progeny of electroporated cells (GFP); blue (A) cell nuclei (DAPI); magenta (B), cycling cells (PCNA). Box (width = 777 µm) indicates area shown at higher magnification in (C). Scale bar = 1 mm. Note the lack of GFP signal in the contralateral (nonelectroporated hemisphere), which serves as an internal control. (C and D) Higher magnifications of the targeted area; green, progeny of electroporated cells (GFP); magenta (C), cycling cells (PCNA); red (D), mitotic cells (phosphohistone 3, PH3). Note that the majority of the progeny of targeted cells was in the SVZ at this stage. Cortical layers as in Figure 1. Please click here to view a larger version of this figure.

Figure 3
Figure 3: Examples of P0 and P16 ferret neocortex after in utero electroporation at E33. (A and B) Section of the P0 ferret neocortex; green, progeny of electroporated cells (GFP); blue (A) cell nuclei (DAPI); cyan (B), Sox2; magenta (B), Tbr2. (B) Higher magnification of the electroporated area. Scale bars = 1 mm (A), 100 µm (B). Cortical layers as in Figure 1. (C) Section of the P16 ferret neocortex; green, progeny of electroporated cells (GFP); grey, cell nuclei (DAPI); magenta, astrocytes (GFAP). Scale bar = 1 mm. This figure has been modified from Kalebic et al.25. Please click here to view a larger version of this figure.

Discussion

In utero electroporation in ferret is an important technique, with advantages and disadvantages with respect to other methods. There are critical steps and limitations to this method, as well as potential modifications and future applications to keep in mind.

Since the pioneering work of Victor Borrell and colleagues on genetic manipulation of the postnatal ferret neocortex via electroporation or viral injection35,42,43, the ferret has become a genetically accessible model organism. Establishing genetic manipulation during embryonic development via in utero electroporation19,20 opened up new research possibilities by allowing targeting of neural progenitor cells at earlier developmental stages. In comparison to postnatal manipulation, in utero electroporation enables targeting of larger areas of the neocortex and less differentiated neural progenitors that sequentially generate all other cell types of the neocortex. Importantly, compared to viral targeting, in utero electroporation allows for spatial precision of targeting.

The most critical part of the method is the surgery itself. In utero electroporation of the ferret neocortex is significantly more complex and difficult in comparison to the procedure in mice. The uterine walls are darker, and the embryos are more difficult to distinguish. Additionally, adult ferrets have greater husbandry and veterinary requirements. Particularly challenging is the period around the birth of the pups. Ferrets are very sensitive in that period and are best not disturbed unnecessarily. The major limitations of the approach itself are related to the efficiency of targeting. In utero electroporation always results in targeting of a mosaic of neural progenitors. This is ideal for studying the cell biological aspects of neural progenitors or neurons, but it is suboptimal for causing large histological and anatomical perturbations, such as a change in neocortical folding. If this is required, the best approach is to move the electrodes along the rostrocaudal axis during the procedure in order to cover large parts of the neocortex. However, for whole organ analysis the best approach is generation of transgenic ferrets starting from the zygote stage44.

The embryonic stage at which the in utero electroporation was performed (E33) is ideal for studying basal progenitors. Indeed, electroporations and viral targeting at this stage have been applied to reveal the timing of the onset of the OSVZ22 as well as various cell biological features of basal progenitors pertinent to their morphology and proliferation21,25,26. However, depending on the scientific purpose of a study, the timing of electroporation can be easily changed without significant modifications to the method19,20. Apart from temporal specificity, in utero electroporation allows for easy modifications of the spatial specificity. The dorsolateral neocortex at the rostromedial position along the rostrocaudal axis was targeted, which resulted in labeling of the motor and somatosensory areas. Other neocortical areas can also be targeted by adjusting the placement of the electrodes and the direction of the electrical field. In mouse, the medial neocortex45 and ventral telencephalon46 have been targeted using in utero electroporation, suggesting that similar approaches could be used in ferrets.

Finally, in utero electroporation can easily be combined with the most recent genome and epigenome editing techniques13,14,16,25, where CRISPR/(d)Cas9 components can be delivered as a plasmid or as a complex of recombinant Cas9 protein and guide RNAs14, with the latter shortening the time required for genome editing to take place. It is likely that further technological improvements in genome editing will be combined with in utero electroporation in both mice and ferrets in order to generate precise genomic mutations important for understanding normal brain development and particularly to model human pathological conditions. In this context, in utero electroporation is being increasingly used as the targeting method of choice for subsequent various single-cell omics approaches and live imaging to understand the molecular signatures and dynamic behavior of the targeted cells and their progeny.

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

We are grateful to the Services and Facilities of the Max Planck Institute of Molecular Cell Biology and Genetics for the outstanding support provided, notably the entire team of the Biomedical services (BMS) for the excellent husbandry of ferrets and J. Peychl and his team of the Light Microscopy Facility. We are particularly grateful to Katrin Reppe and Anna Pfeffer from the BMS for exceptional veterinary support and Lei Xing from the Huttner group for assisting with ferret surgeries.

Materials

1ml syringe BD 309628 Electroporation
4-0 Vicryl suture Ethicon V392ZG Surgery
Aluminium spray cp-pharma 98017 Surgery
Amoxicilin+clavulanic acid (Synulox RTU) WDT 6301 Surgery
Cappilary holder WPI MPH6S12 Electroporation
Dexpanthenol Ointment solution Bayer 6029009.00.00 Surgery
Drape sheet 45x75cm Hartmann 2513052 Surgery
Electrode Tweezer, platinum plated 5mm BTX 45-0489 Electroporation
Electroporator BTX ECM830 Electroporation
Fast Green Sigma F7258-25G Electroporation
Ferret Mustela putorius furo Marshall NA Experimental organism
Fiber optic light source Olympus KL1500LCD Electroporation
Forceps Allgaier instrumente 08-033-130 Surgery
Forceps 3C-SA Rubis Tech 3C-SA Surgery
Forceps 55 Dumostar 11295-51 Surgery
Forceps 5-SA Rubis Tech 5-SA Surgery
Gauze swabs large Hartmann 401723 Surgery
Gauze swabs small Hartmann 401721 Surgery
GFAP antibody Dako Z0334 Antibody
GFP antibody Aves labs GFP1020 Antibody
Glass cappilaries (Borosilicate glass with filament, OD:1.2mm, ID: 0.69mm, 10cm length) Sutter Instrument BF120-69-10 Electroporation
Glucose Bela-pharm K4011-02 Surgery
Heat pad Hans Dinslage Sanitas SHK18 Surgery
Iodine (Betadine solution 100 mg/ml) Meda 997437 Surgery
Isofluran CP 21311 Surgery
Loading tips 20µl Eppendorf #5242 956.003 Electroporation
Metamizol WDT 99012 Surgery
Metzenbaum dissecting scissors Aesculap BC600R Surgery
Micropipette puller Sutter Instrument Model P-97 Electroporation
pCAGGS-GFP NA NA From Kalebic et al., eLife, 2018
PCNA antibody Millipore CBL407 Antibody
pH3 antibody Abcam ab10543 Antibody
Scalpel Aesculap 294200104 Surgery
Shaver Braun EP100 Surgery
Sox2 antibody R+D Systems AF2018 Antibody
Surgical clamp 13cm WDT 27080 Surgery
Surgical double spoon (Williger) WDT 27232 Surgery
Surgical drape WDT 28800 Surgery
Surgical scissors small FST 14090-09 Surgery
Suturing needle holder Aesculap BM149R Surgery
Tbr2 antibody Abcam ab23345 Antibody
Transfer pipette 3ml Fischer scientific 13439108 Surgery
Water bath Julabo TW2 Surgery

Riferimenti

  1. Kalebic, N., Long, K., Huttner, W. B., Kaas, J. . Evolution of Nervous Systems 2e. 3, 73-89 (2017).
  2. Rakic, P. Evolution of the neocortex: a perspective from developmental biology. Nature Reviews Neurosciences. 10 (10), 724-735 (2009).
  3. Dehay, C., Kennedy, H., Kosik, K. S. The outer subventricular zone and primate-specific cortical complexification. Neuron. 85 (4), 683-694 (2015).
  4. Fernandez, V., Llinares-Benadero, C., Borrell, V. Cerebral cortex expansion and folding: what have we learned. EMBO Journal. 35 (10), 1021-1044 (2016).
  5. Molnar, Z., et al. New insights into the development of the human cerebral cortex. Journal of Anatomy. 235 (3), 432-451 (2019).
  6. Janson, C. G., McPhee, S. W., Leone, P., Freese, A., During, M. J. Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends in Neurosciences. 24 (12), 706-712 (2001).
  7. Tabata, H., Nakajima, K. Labeling embryonic mouse central nervous system cells by in utero electroporation. Development Growth & Differentiation. 50 (6), 507-511 (2008).
  8. Neumann, E., Schaefer-Ridder, M., Wang, Y., Hofschneider, P. H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO Journal. 1 (7), 841-845 (1982).
  9. Saito, T., Nakatsuji, N. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Biologia dello sviluppo. 240 (1), 237-246 (2001).
  10. Tabata, H., Nakajima, K. Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex. Neuroscienze. 103 (4), 865-872 (2001).
  11. Walantus, W., Castaneda, D., Elias, L., Kriegstein, A. In utero intraventricular injection and electroporation of E15 mouse embryos. Journal of Visualized Experiments. (6), e239 (2007).
  12. Straub, C., Granger, A. J., Saulnier, J. L., Sabatini, B. L. CRISPR/Cas9-mediated gene knock-down in post-mitotic neurons. PLoS One. 9 (8), 105584 (2014).
  13. Shinmyo, Y., et al. CRISPR/Cas9-mediated gene knockout in the mouse brain using in utero electroporation. Science Reports. 6, 20611 (2016).
  14. Kalebic, N., et al. CRISPR/Cas9-induced disruption of gene expression in mouse embryonic brain and single neural stem cells in vivo. EMBO Reports. 17 (3), 338-348 (2016).
  15. Mikuni, T., Nishiyama, J., Sun, Y., Kamasawa, N., Yasuda, R. High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing. Cell. 165 (7), 1803-1817 (2016).
  16. Albert, M., et al. Epigenome profiling and editing of neocortical progenitor cells during development. EMBO Journal. 36 (17), 2642-2658 (2017).
  17. Takahashi, M., Sato, K., Nomura, T., Osumi, N. Manipulating gene expressions by electroporation in the developing brain of mammalian embryos. Differentiation. 70 (4-5), 155-162 (2002).
  18. Walantus, W., Elias, L., Kriegstein, A. In utero intraventricular injection and electroporation of E16 rat embryos. Journal of Visualized Experiments. (6), e236 (2007).
  19. Kawasaki, H., Iwai, L., Tanno, K. Rapid and efficient genetic manipulation of gyrencephalic carnivores using in utero electroporation. Molecular Brain. 5, 24 (2012).
  20. Kawasaki, H., Toda, T., Tanno, K. In vivo genetic manipulation of cortical progenitors in gyrencephalic carnivores using in utero electroporation. Biology Open. 2 (1), 95-100 (2013).
  21. Kalebic, N., et al. Neocortical expansion due to increased proliferation of basal progenitors is linked to changes in their morphology. Cell Stem Cell. 24 (4), 535-550 (2019).
  22. Martinez-Martinez, M. A., et al. A restricted period for formation of outer subventricular zone defined by Cdh1 and Trnp1 levels. Nature Communication. 7, 11812 (2016).
  23. Saito, K., et al. Characterization of the Inner and Outer Fiber Layers in the Developing Cerebral Cortex of Gyrencephalic Ferrets. Cerebral Cortex. 29 (10), 4303-4311 (2019).
  24. Shinmyo, Y., et al. Folding of the Cerebral Cortex Requires Cdk5 in Upper-Layer Neurons in Gyrencephalic Mammals. Cell Reports. 20 (9), 2131-2143 (2017).
  25. Matsumoto, N., Shinmyo, Y., Ichikawa, Y., Kawasaki, H. Gyrification of the cerebral cortex requires FGF signaling in the mammalian brain. Elife. 6, 29285 (2017).
  26. Kalebic, N., et al. Human-specific ARHGAP11B induces hallmarks of neocortical expansion in developing ferret neocortex. Elife. 7, 41241 (2018).
  27. Masuda, K., et al. Pathophysiological analyses of cortical malformation using gyrencephalic mammals. Science Reports. 5, 15370 (2015).
  28. Matsumoto, N., et al. Pathophysiological analyses of periventricular nodular heterotopia using gyrencephalic mammals. Human Molecular Genetics. 26 (6), 1173-1181 (2017).
  29. Barnette, A. R., et al. Characterization of brain development in the ferret via MRI. Pediatric Research. 66 (1), 80-84 (2009).
  30. Smart, I. H., McSherry, G. M. Gyrus formation in the cerebral cortex in the ferret. I. Description of the external changes. Journal of Anatomy. 146, 141-152 (1986).
  31. Sawada, K., Watanabe, M. Development of cerebral sulci and gyri in ferrets (Mustela putorius). Congenital Anomalies (Kyoto). 52 (3), 168-175 (2012).
  32. Reillo, I., Borrell, V. Germinal zones in the developing cerebral cortex of ferret: ontogeny, cell cycle kinetics, and diversity of progenitors. Cerebral Cortex. 22 (9), 2039-2054 (2012).
  33. Smart, I. H., McSherry, G. M. Gyrus formation in the cerebral cortex of the ferret. II. Description of the internal histological changes. Journal of Anatomy. 147, 27-43 (1986).
  34. Borrell, V., Reillo, I. Emerging roles of neural stem cells in cerebral cortex development and evolution. Developmental Neurobiology. 72 (7), 955-971 (2012).
  35. Reillo, I., de Juan Romero, C., Garcia-Cabezas, M. A., Borrell, V. A role for intermediate radial glia in the tangential expansion of the mammalian cerebral cortex. Cerebral Cortex. 21 (7), 1674-1694 (2011).
  36. Fietz, S. A., et al. OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling. Nature Neurosciences. 13 (6), 690-699 (2010).
  37. Lui, J. H., Hansen, D. V., Kriegstein, A. R. Development and evolution of the human neocortex. Cell. 146 (1), 18-36 (2011).
  38. Fietz, S. A., Huttner, W. B. Cortical progenitor expansion, self-renewal and neurogenesis-a polarized perspective. Current Opinion in Neurobiology. 21 (1), 23-35 (2011).
  39. De Juan Romero, C., Bruder, C., Tomasello, U., Sanz-Anquela, J. M., Borrell, V. Discrete domains of gene expression in germinal layers distinguish the development of gyrencephaly. EMBO Journal. 34 (14), 1859-1874 (2015).
  40. Kawasaki, H. Molecular investigations of the brain of higher mammals using gyrencephalic carnivore ferrets. Neurosciences Research. 86, 59-65 (2014).
  41. Matsui, A., Yoshida, A. C., Kubota, M., Ogawa, M., Shimogori, T. Mouse in utero electroporation: controlled spatiotemporal gene transfection. Journal of Visualized Experiments. (54), e3024 (2011).
  42. Borrell, V. In vivo gene delivery to the postnatal ferret cerebral cortex by DNA electroporation. Journal of Neuroscience Methods. 186 (2), 186-195 (2010).
  43. Borrell, V., Kaspar, B. K., Gage, F. H., Callaway, E. M. In vivo evidence for radial migration of neurons by long-distance somal translocation in the developing ferret visual cortex. Cerebral Cortex. 16 (11), 1571-1583 (2006).
  44. Johnson, M. B., et al. Aspm knockout ferret reveals an evolutionary mechanism governing cerebral cortical size. Nature. 556 (7701), 370-375 (2018).
  45. Vaid, S., et al. A novel population of Hopx-dependent basal radial glial cells in the developing mouse neocortex. Development. 145 (20), 169276 (2018).
  46. Pilz, G. A., et al. Amplification of progenitors in the mammalian telencephalon includes a new radial glial cell type. Nature Communications. 4, 2125 (2013).

Play Video

Citazione di questo articolo
Kalebic, N., Langen, B., Helppi, J., Kawasaki, H., Huttner, W. B. In Vivo Targeting of Neural Progenitor Cells in Ferret Neocortex by In Utero Electroporation. J. Vis. Exp. (159), e61171, doi:10.3791/61171 (2020).

View Video